As previously reported, Wolfe Research analyst Doug Schenkel initiated coverage of Grail (GRAL) with a Peer Perform rating and no price target ...

Tobin Marcus, Wolfe Research policy and politics head, joins CNBC's 'Squawk Box' to discuss what Trump's pick for HHS ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.09% of ...

Fintel reports that on November 14, 2024, Wolfe Research initiated coverage of Repligen (NasdaqGS:RGEN) with a Peer Perform ...

Wolfe Research has upgraded Warner Bros. Discovery (WBD, Financials) to "peer perform" from "underperform," citing a balanced risk/reward outlook despite Warner Bros. Discoverys $40 billion in ...

Wolfe Research has recently raised Warner Bros Discovery Inc (WBD) stock to Peer Perform rating, as announced on November 11, 2024, according to Finviz. Earlier, on August 13, 2024, Bernstein had ...

agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the 2024 Wolfe Research Healthcare ...

Wolfe Research initiated coverage of BioMarin (BMRN) with an Outperform rating and $95 price target With limited downside risk following ...